Lisdexamfetamine Dimesylate 47781-0566-01
- Manufacturer
- Alvogen Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- August 25, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA214547
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 50 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
47781-0566-01Selected100 CAPSULE in 1 BOTTLE (47781-566-01)